DP

Devender Pal Singh

Active Director Director DIN 00118090
DIN 00118090 First appointment Apr 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Apr 2000
Shareholding value •••• Premium profile

About Devender Pal Singh

Data last updated:

Devender Pal Singh is a Director at Doschemen Pharmaceuticals Private Limited (since 2014) and Director at Surendra Consultancy Services Private Limited (since 2004). The companies operate in Pharma, Business Outsourcing and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹1.04 Cr; the largest is Doschemen Pharmaceuticals Private Limited at ₹100 Lakh (FY 2025). Earlier, Devender Pal Singh was a Director at Emul Tek Private Limited (2001–2009) and Director at Raipur Iron & Steel Co. Private Limited (2009–2013) and 4 more.

DIN 00118090
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2000
Oldest Company Age 22 yrs
Largest company Doschemen Pharmaceuticals Private Limited · ₹100 Lakh (FY 2025)
Combined revenue ₹1.04 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20142014₹100 Lakh (FY 2025)Active
Director15 Mar 20042004₹3.5 Lakh (FY 2021)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emul Tek Private Limited U24292MH2000PTC274027
Director16 Apr 20012000₹299 Cr (FY 2025)Active
Director03 Nov 20092008₹77,000 (FY 2025)Active
Bulk Tec Private Limited U24292RJ2001PTC096759
Director02 Dec 20052001₹52,270 (FY 2025)Active
Blastec (India) Private Limited U74999MH2000PTC274886
Director18 Apr 20002000₹10.64 Cr (FY 2021)Amalgamated
S A Portfolio Limited U74899DL1995PLC065136
Director04 Jan 20021995₹60.4 Lakh (FY 2025)Active
Partner16 Jun 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Devender Pal Singh

Directorship timeline

Open interactive timeline →
Surendra Consultancy Services Private Limited
Doschemen Pharmaceuticals Private Limited
Emul Tek Private Limited
Raipur Iron & Steel Co. Private Limited
Premium access

Shareholding and investment profile for Devender Pal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devender Pal Singh

Devender Pal Singh currently holds 2 directorships: Doschemen Pharmaceuticals Private Limited (Director, since 03 Sep 2014, revenue ₹100 Lakh (FY 2025)); Surendra Consultancy Services Private Limited (Director, since 15 Mar 2004, revenue ₹3.5 Lakh (FY 2021)).

Devender Pal Singh was first appointed on 18 Apr 2000 as Director at Blastec (India) Private Limited. The most recent appointment on record is 16 Jun 2017 at San Deltin Polychem Llp.

The 2 current companies of Devender Pal Singh that report revenue have a combined latest revenue of ₹1.04 Cr: Doschemen Pharmaceuticals Private Limited ₹100 Lakh (FY 2025); Surendra Consultancy Services Private Limited ₹3.5 Lakh (FY 2021).

Devender Pal Singh held 6 earlier board appointments: Emul Tek Private Limited (Director, 16 Apr 2001 to 05 Oct 2009); Raipur Iron & Steel Co. Private Limited (Director, 03 Nov 2009 to 28 Nov 2013); Bulk Tec Private Limited (Director, 02 Dec 2005 to 15 Apr 2009); Blastec (India) Private Limited (Director, 18 Apr 2000 to 15 Apr 2009); S A Portfolio Limited (Director, 04 Jan 2002 to 28 Jul 2014); and 1 more.

The current boards of Devender Pal Singh's companies include Tarvindar Kaur (Doschemen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available